http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09509963-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 |
| filingDate | 1995-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1997-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H09509963-A |
| titleOfInvention | Thiazolidinedione derivatives as anti-hyperglycemic agents |
| abstract | (57) [Summary] The present invention provides compounds represented by the general formula (I): [Wherein Ar is phenyl, 2-naphthyl, alkyl-substituted phenyl, alkoxy-substituted phenyl, halogen-substituted phenyl, 2-pyridinyl, substituted 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 2-quinolinyl, 2-pyrimidinyl, 2 -Benzoxazolyl, 2-benzthiazolyl, 2-benzimidazolyl, 2-furanyl, 2-benzo- [b] -furanyl, 2-thienyl, 2-benzo- [b] -thienyl; n is 0 or 2; and Ar 'is a novel 5- [3-aryl-prop-2-, characterized by phenyl, alkyl-substituted phenyl, perfluoroalkyl-substituted phenyl, halogen-substituted phenyl, alkoxy-substituted phenyl, perfluoroalkoxy-substituted phenyl and alkylthio-substituted phenyl]. Inyl] -5- (arylsulfonyl) -thiazolidine-2,4-dione and 5- [3-aryl- LOP-2-ynyl] -5- about (arylsulfanyl) thiazolidine-2,4-dione. The invention also relates to the use of said compounds for lowering blood glucose levels in a hyperglycemic mammal, as well as pharmaceutical compositions containing the same. |
| priorityDate | 1994-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 116.